SCM
MRNA icon

Sterling Capital Management’s Moderna MRNA Stock Holding History

Sterling Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767K Sell
10,948
-1,130
-9% -$58.5K 0.01% 645
2026
Q1 		$614K Sell
12,078
-9,166
-43% -$428K 0.01% 677
2025
Q4 		$626K Sell
21,244
-687
-3% -$18.7K 0.01% 834
2025
Q3 		$566K Sell
21,931
-1,680
-7% -$46.9K 0.01% 876
2025
Q2 		$641K Buy
23,611
+22,673
+2,417% +$597K 0.01% 798
2025
Q1 		$26.6K Hold
938
– – ﹤0.01% 1574
2024
Q4 		$39K Sell
938
-487
-34% -$23.3K ﹤0.01% 1684
2024
Q3 		$95.2K Buy
+1,425
New +$131K ﹤0.01% 1401

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Sterling Capital Management's MRNA Position: Q2 2026 in Review

Sterling Capital Management reduced its Moderna (MRNA) stake by 9.4% in Q2 2026, selling an estimated $58.5K and leaving 10,948 shares worth $767K. The position accounts for 0.01% of the portfolio, ranked #645.

Sterling Capital Management first reported a position in MRNA in Q3 2024 and has held it in 8 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Sterling Capital Management held 10,948 shares of Moderna worth $767K as of Q2 2026.
  • Sterling Capital Management sold 1,130 Moderna shares in Q2 2026, an estimated $58.5K.
  • Moderna made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #645 holding.
  • Sterling Capital Management first reported a position in Moderna in Q3 2024 and has held it in 8 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.